Guaifenesin 81033-0102-16
- Manufacturer
- Kesin Pharma Corporation
- Dosage Form
- Liquid
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- November 20, 2023
- Listing Expires
- December 31, 2026
- Application
- M012
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 100 mg/5mL |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(2)
50 CUP, UNIT-DOSE in 1 CARTON (81033-102-51) / 5 mL in 1 CUP, UNIT-DOSE (81033-102-05)
50 CUP, UNIT-DOSE in 1 CARTON (81033-102-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-102-10)